Applications
Through our proprietary multi-arm PEGs, polydisperse PEG, and non-PEG linkers, we enable the construction of diverse biomaterial architectures with tunable properties. From hydrogel formation to surface modification, we provide the core tools for engineering advanced biomaterials for biomedical applications.
Through our proprietary homobifunctional PEG linkers, heterobifunctional PEG linkers, and biotinylation reagents, we enable the site-specific and efficient conjugation of antibodies, proteins, and nucleic acids. From stable linkage to functional labeling, we provide the core tools for building next-generation bioconjugates.
Through our proprietary PEGylation reagents, site-specific linkers, and biotinylation reagents, we enable targeted and controlled modification of therapeutic proteins. From enhanced circulation half-life to functional labeling, we provide the core tools for optimizing protein therapeutics.
Through our proprietary PEGylation reagents, diselenide linkers, and STING agonists, we enable prolonged circulation and intelligent responsiveness of nanocarriers. From passive targeting to immune activation, we provide the core tools for engineering smart nanomedicines.
Through our proprietary clickable linkers, cleavable linkers, and PEG lipids, we enable precise homing and on-demand release of delivery systems. From surface functionalization to intracellular controlled release, we provide the core tools for constructing actively targeting formulations.
- Peptide-PEG Conjugates
- Site Specific Linkers
- PEGylation Reagents
Through our proprietary peptide-PEG conjugates, site-specific linkers, and PEGylation reagents, we enable controlled payload release, homogeneous conjugation, and optimized pharmacokinetics of ADCs. From enzyme-cleavable peptide sequences to enhanced solubility and stability, we provide the core tools for building next-generation antibody-drug conjugates.
Through our proprietary PROTAC building blocks, heterobifunctional PEG linkers, and clickable linkers, we enable the targeted degradation of disease-relevant proteins. From ternary complex formation to modular assembly, we provide the core tools for developing next-generation PROTAC therapeutics.
Through our proprietary porphyrin photosensitizers, PEGylation reagents, and multi-arm PEGs, we enable efficient photosensitizer delivery and enhanced tumor accumulation. From improved solubility to targeted photodynamic effect, we provide the core tools for advancing photodynamic therapy.
Through our proprietary chelating agents, biotinylation reagents, and diazirine linkers, we enable sensitive detection and precise molecular capture. From radiolabeled imaging probes to photoaffinity labeling, we provide the core tools for developing advanced molecular diagnostics.
